Single-agent chemotherapy should be the standard arm against which experimental treatments are tested in randomized trials didicated to PS 2 patients.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content